Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Karl S. Lang; Mike Recher; Tobias Junt; Alexander A. Navarini; Nicola L. Harris; Stefan Freigang; Bernhard Odermatt; Curdin Conrad; Lars M. Ittner; Stefan Bauer; Sanjiv A. Luther; Satoshi Uematsu; Akira Shizuo; Hans Hengartner; Rolf M. Zinkernagel

doi:10.1038/nm1176

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Nature Medicine 11(2): 138-145

Article 2005 English

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Corrigendum2005

Erratum: Corrigendum: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Karl S. Lang, Mike Recher, Tobias Junt, Alexander A. Navarini, Nicola L. Harris, Stefan Freigang, Bernhard Odermatt, Curdin Conrad, Lars M. Ittner, Stefan Bauer, Sanjiv A. Luther, Satoshi Uematsu, Akira Shizuo, Hans Hengartner, R M Zinkernagel

Article2007

The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases

Eva M. Pålsson‐McDermott, Luke O'neill

Irish Journal of Medical Science (1971 -)

Article2004

Toll-like receptor signalling

Akira Shizuo, Kiyoshi Takeda

Nature reviews. Immunology

Letter2006

DisSARMing Toll-like receptor signaling

Luke O'neill

Nature Immunology

Article2002

Toll-like receptors: new therapeutic targets for autoimmune diseases

Luke O'neill

Trends in Pharmacological Sciences

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

Abstract

Discussion(0)

Related publications

Erratum: Corrigendum: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases

Toll-like receptor signalling

DisSARMing Toll-like receptor signaling

Toll-like receptors: new therapeutic targets for autoimmune diseases